OverviewChartTechnicalNewsTraderScreen

Codexis Inc/  US1920051067  /

NASDAQ
29/05/2024  22:00:00 Chg. +0.0400 Volume Bid12:22:24 Ask12:22:24 High Low
3.1900USD +1.27% 438,494
Turnover: 963,232.6067		 3.0600Bid Size: 500 3.4600Ask Size: 1,000 3.2000 3.0274
GlobeNewswire 22/05 Codexis to Participate in Jefferies Global Healthcare Conference
GlobeNewswire 20/05 Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
GlobeNewswire 14/05 Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
GlobeNewswire 06/05 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 02/05 Codexis Reports First Quarter 2024 Financial Results
GlobeNewswire 18/04 Codexis to Report First Quarter 2024 Financial Results on May 2
GlobeNewswire 11/04 Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
GlobeNewswire 28/02 Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
GlobeNewswire 26/02 Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Ro...
GlobeNewswire 26/02 Codexis to Participate in TD Cowen 44th Annual Health Care Conference
GlobeNewswire 20/02 Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
GlobeNewswire 14/02 Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
GlobeNewswire 13/02 Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further S...
GlobeNewswire 01/02 seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT Genera...
GlobeNewswire 27/12/2023 Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108
GlobeNewswire 13/12/2023 Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
GlobeNewswire 13/12/2023 Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform
GlobeNewswire 11/12/2023 Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeuti...
GlobeNewswire 28/11/2023 Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics...
GlobeNewswire 14/11/2023 Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference
GlobeNewswire 03/11/2023 INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Codexis, Inc.; Urges Codexis Stockho...
GlobeNewswire 02/11/2023 Codexis Reports Third Quarter 2023 Financial Results
GlobeNewswire 31/10/2023 Codexis to Participate in Upcoming Healthcare Conferences
GlobeNewswire 27/10/2023 Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
GlobeNewswire 26/10/2023 Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe